- Home
- IVR vs BBOT Comparison
IVR vs BBOT Comparison
Compare IVR & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IVR | BBOT |
|---|---|---|
| Founded | 2008 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 758.8M | 717.8M |
| IPO Year | 2008 | 2024 |
Fundamental Metrics
Financial Performance| Metric | IVR | BBOT |
|---|---|---|
| Price | $7.15 | $8.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $8.25 | ★ $24.00 |
| AVG Volume (30 Days) | ★ 2.3M | 237.4K |
| Earning Date | 04-30-2026 | 05-26-2026 |
| Dividend Yield | ★ 17.80% | N/A |
| EPS Growth | ★ 103.08 | 99.93 |
| EPS | ★ 0.10 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $150.63 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $71.40 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.10 | $7.00 |
| 52 Week High | $9.50 | $14.87 |
Technical Indicators
Market Signals| Indicator | IVR | BBOT |
|---|---|---|
| Relative Strength Index (RSI) | 34.63 | 47.64 |
| Support Level | N/A | $8.80 |
| Resistance Level | $7.63 | $9.53 |
| Average True Range (ATR) | 0.10 | 0.45 |
| MACD | -0.02 | -0.07 |
| Stochastic Oscillator | 16.03 | 29.19 |
Price Performance
Historical ComparisonAbout IVR INVESCO MORTGAGE CAPITAL INC
Invesco Mortgage Capital Inc is a REIT that invests, finances, and manages residential and commercial mortgage-backed securities and mortgage loans. The company's portfolio consists of residential mortgage-backed securities (RMBS) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association, or a federally chartered corporation such as the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation; Commercial mortgage-backed securities (CMBS) that are not guaranteed by a U.S. government agency or a federally chartered corporation; RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation; and other real estate-related financing arrangements.
About BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.